{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T04:14:52Z","timestamp":1773980092354,"version":"3.50.1"},"reference-count":109,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,12,4]],"date-time":"2017-12-04T00:00:00Z","timestamp":1512345600000},"content-version":"vor","delay-in-days":2133,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["bjanaesthesia.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["British Journal of Anaesthesia"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1093\/bja\/aer461","type":"journal-article","created":{"date-parts":[[2012,1,5]],"date-time":"2012-01-05T18:54:38Z","timestamp":1325789678000},"page":"183-192","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Management of the dialysis patient in general intensive care"],"prefix":"10.1016","volume":"108","author":[{"given":"N.","family":"Arulkumaran","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.M.","family":"Montero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Singer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1093\/bja\/aer461_bib1","series-title":"USRDS 2009 Annual Data Report","author":"US Renal Data System","year":"2009"},{"key":"10.1093\/bja\/aer461_bib2","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1056\/NEJMp058318","article-title":"Chronic kidney disease in the developing world","volume":"354","author":"Barsoum","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1093\/bja\/aer461_bib3","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1681\/ASN.2007020220","article-title":"End-stage renal disease in the United States: an update from the United States Renal Data System","volume":"18","author":"Foley","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"10.1093\/bja\/aer461_bib4","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1001\/jama.298.17.2038","article-title":"Prevalence of chronic kidney disease in the United States","volume":"298","author":"Coresh","year":"2007","journal-title":"J Am Med Assoc"},{"key":"10.1093\/bja\/aer461_bib5","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa041031","article-title":"Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization","volume":"351","author":"Go","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1093\/bja\/aer461_bib6","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/S0085-2538(15)50904-6","article-title":"Survival of dialysis patients after cardiac arrest and the impact of implantable cardioverter defibrillators","volume":"68","author":"Herzog","year":"2005","journal-title":"Kidney Int"},{"key":"10.1093\/bja\/aer461_bib7","doi-asserted-by":"crossref","first-page":"R50","DOI":"10.1186\/cc5785","article-title":"Case mix, outcome and activity for patients admitted to intensive care units requiring chronic renal dialysis: a secondary analysis of the ICNARC Case Mix Programme Database","volume":"11","author":"Hutchison","year":"2007","journal-title":"Crit Care"},{"key":"10.1093\/bja\/aer461_bib8","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1159\/000069156","article-title":"End-stage renal failure patients requiring renal replacement therapy in the intensive care unit: incidence, clinical features, and outcome","volume":"21","author":"Uchino","year":"2003","journal-title":"Blood Purif"},{"key":"10.1093\/bja\/aer461_bib9","series-title":"NKF KDOQUI Guidelines 2000","author":"NKF-National Kidney Foundation U","year":"2000"},{"key":"10.1093\/bja\/aer461_bib10","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.bpa.2003.09.010","article-title":"Vascular access for dialysis in the intensive care unit","volume":"18","author":"Canaud","year":"2004","journal-title":"Best Pract Res Clin Anaesthesiol"},{"key":"10.1093\/bja\/aer461_bib11","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s11906-002-0068-4","article-title":"Hypertension as a cardiovascular risk factor in end-stage renal failure","volume":"4","author":"Zoccali","year":"2002","journal-title":"Curr Hypertens Rep"},{"key":"10.1093\/bja\/aer461_bib12","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1046\/j.1523-1755.2002.00099.x","article-title":"Relationship between volume status and blood pressure during chronic hemodialysis","volume":"61","author":"Leypoldt","year":"2002","journal-title":"Kidney Int"},{"key":"10.1093\/bja\/aer461_bib13","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1159\/000070242","article-title":"Volume control, blood pressure and cardiovascular function. Lessons from hemodialysis treatment","volume":"93","author":"Charra","year":"2003","journal-title":"Nephron Physiol"},{"key":"10.1093\/bja\/aer461_bib14","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1046\/j.1523-1755.2001.059002754.x","article-title":"Effect of cause and time of dropout on the residual GFR: a comparative analysis of the decline of GFR on dialysis","volume":"59","author":"Misra","year":"2001","journal-title":"Kidney Int"},{"key":"10.1093\/bja\/aer461_bib15","article-title":"Acute pulmonary oedema in chronic dialysis patients admitted into an intensive care unit","author":"Halle","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"10.1093\/bja\/aer461_bib16","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1525-139X.2004.17110.x","article-title":"Nondialytic management of hyperkalemia and pulmonary edema among end-stage renal disease patients: an evaluation of the evidence","volume":"17","author":"Evans","year":"2004","journal-title":"Semin Dial"},{"key":"10.1093\/bja\/aer461_bib17","first-page":"47","article-title":"Phlebotomy for pulmonary edema in dialysis patients","volume":"47","author":"Eiser","year":"1997","journal-title":"Clin Nephrol"},{"key":"10.1093\/bja\/aer461_bib18","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1159\/000320370","article-title":"Sudden death in hemodialysis: an update","volume":"30","author":"Kanbay","year":"2010","journal-title":"Blood Purif"},{"key":"10.1093\/bja\/aer461_bib19","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1161\/HYPERTENSIONAHA.110.151167","article-title":"Sudden cardiac death in end-stage renal disease patients: a 5-year prospective analysis","volume":"56","author":"Wang","year":"2010","journal-title":"Hypertension"},{"key":"10.1093\/bja\/aer461_bib20","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1080\/08860220701191237","article-title":"Prevalence and predictors of arrhythmia in end stage renal disease patients on hemodialysis","volume":"29","author":"Bozbas","year":"2007","journal-title":"Ren Fail"},{"key":"10.1093\/bja\/aer461_bib21","first-page":"460","article-title":"Changes in QT intervals in patients with end-stage renal disease before and after hemodialysis","volume":"21","author":"Malhis","year":"2010","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"10.1093\/bja\/aer461_bib22","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/ki.2010.315","article-title":"Modifiable risk factors associated with sudden cardiac arrest within hemodialysis clinics","volume":"79","author":"Pun","year":"2011","journal-title":"Kidney Int"},{"key":"10.1093\/bja\/aer461_bib23","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1053\/j.ajkd.2011.03.026","article-title":"Trends in the use and outcomes of implantable cardioverter-defibrillators in patients undergoing dialysis in the United States","volume":"58","author":"Charytan","year":"2011","journal-title":"Am J Kidney Dis"},{"key":"10.1093\/bja\/aer461_bib24","doi-asserted-by":"crossref","first-page":"35","DOI":"10.5414\/CNP59035","article-title":"Differential use of cardiac troponin T versus I in hemodialysis patients","volume":"59","author":"Fehr","year":"2003","journal-title":"Clin Nephrol"},{"key":"10.1093\/bja\/aer461_bib25","first-page":"979","article-title":"Prevalence of elevated troponin I in end-stage renal disease patients receiving hemodialysis","volume":"11","author":"Donnino","year":"2004","journal-title":"Acad Emerg Med"},{"key":"10.1093\/bja\/aer461_bib26","doi-asserted-by":"crossref","first-page":"578","DOI":"10.3109\/0886022X.2011.585264","article-title":"The comparison of cardiac biomarkers positivities in hemodialysis patients without acute coronary syndrome","volume":"33","author":"Korkmaz","year":"2011","journal-title":"Ren Fail"},{"key":"10.1093\/bja\/aer461_bib27","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/j.1365-2362.2007.01785.x","article-title":"Cardiac biomarkers and survival in haemodialysis patients","volume":"37","author":"Sommerer","year":"2007","journal-title":"Eur J Clin Invest"},{"key":"10.1093\/bja\/aer461_bib28","doi-asserted-by":"crossref","first-page":"392","DOI":"10.5414\/CNP68392","article-title":"Cardiac biomarkers are influenced by dialysis characteristics","volume":"68","author":"Sommerer","year":"2007","journal-title":"Clin Nephrol"},{"key":"10.1093\/bja\/aer461_bib29","doi-asserted-by":"crossref","first-page":"c77","DOI":"10.1159\/000108647","article-title":"Cardiac biomarkers in haemodialysis patients: the prognostic value of amino-terminal pro-B-type natriuretic peptide and cardiac troponin T","volume":"107","author":"Sommerer","year":"2007","journal-title":"Nephron Clin Pract"},{"key":"10.1093\/bja\/aer461_bib30","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1093\/eurjhf\/hfr057","article-title":"Increasing B-type natriuretic peptide levels predict mortality in unselected haemodialysis patients","volume":"13","author":"Breidthardt","year":"2011","journal-title":"Eur J Heart Fail"},{"key":"10.1093\/bja\/aer461_bib31","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1093\/ndt\/gfn730","article-title":"Prognostic value of elevated cardiac troponin I in ESRD patients with sepsis","volume":"24","author":"Kang","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"10.1093\/bja\/aer461_bib32","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1111\/j.1523-1755.2000.00337.x","article-title":"Mortality caused by sepsis in patients with end-stage renal disease compared with the general population","volume":"58","author":"Sarnak","year":"2000","journal-title":"Kidney Int"},{"key":"10.1093\/bja\/aer461_bib33","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/0140-6736(92)90865-Z","article-title":"Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure","volume":"339","author":"Vallance","year":"1992","journal-title":"Lancet"},{"key":"10.1093\/bja\/aer461_bib34","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/ki.1992.332","article-title":"Plasma tumor necrosis factor soluble receptors in chronic renal failure","volume":"42","author":"Brockhaus","year":"1992","journal-title":"Kidney Int"},{"key":"10.1093\/bja\/aer461_bib35","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/ki.1991.276","article-title":"Anti-interleukin-1 alpha autoantibodies in hemodialysis patients","volume":"40","author":"Sunder-Plassmann","year":"1991","journal-title":"Kidney Int"},{"key":"10.1093\/bja\/aer461_bib36","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1093\/oxfordjournals.ndt.a027346","article-title":"Influence of uraemia and haemodialysis on host defence and infection","volume":"11","author":"Vanholder","year":"1996","journal-title":"Nephrol Dial Transplant"},{"key":"10.1093\/bja\/aer461_bib37","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1056\/NEJMoa010307","article-title":"Early goal-directed therapy in the treatment of severe sepsis and septic shock","volume":"345","author":"Rivers","year":"2001","journal-title":"N Engl J Med"},{"issue":"suppl. 1","key":"10.1093\/bja\/aer461_bib38","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/cc2630","article-title":"Early goal-directed therapy in patients with end-stage renal disease. 24th International Symposium on Intensive Care and Emergency Medicine. Brussels, Belgium","volume":"8","author":"Donnino","year":"2004","journal-title":"Crit Care"},{"key":"10.1093\/bja\/aer461_bib39","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1023\/A:1024466206414","article-title":"Pyocystis in patients on chronic dialysis. A potentially misdiagnosed syndrome","volume":"34","author":"Bibb","year":"2002","journal-title":"Int Urol Nephrol"},{"key":"10.1093\/bja\/aer461_bib40","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.2215\/CJN.01230406","article-title":"Comparison of infectious complications between incident hemodialysis and peritoneal dialysis patients","volume":"1","author":"Aslam","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1093\/bja\/aer461_bib41","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1053\/j.ajkd.2008.06.032","article-title":"Associations of dialysis modality and infectious mortality in incident dialysis patients in Australia and New Zealand","volume":"53","author":"Johnson","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"10.1093\/bja\/aer461_bib42","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/S0272-6386(99)70018-1","article-title":"Bacteremia associated with tunneled, cuffed hemodialysis catheters","volume":"34","author":"Saad","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"10.1093\/bja\/aer461_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1523-1755.2001.00765.x","article-title":"Infectious complications of the hemodialysis access","volume":"60","author":"Nassar","year":"2001","journal-title":"Kidney Int"},{"key":"10.1093\/bja\/aer461_bib44","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1093\/ndt\/gfh467","article-title":"Tesio-Caths provide effective and safe long-term vascular access","volume":"19","author":"Duncan","year":"2004","journal-title":"Nephrol Dial Transplant"},{"issue":"suppl. 1","key":"10.1093\/bja\/aer461_bib45","doi-asserted-by":"crossref","first-page":"c261","DOI":"10.1159\/000301235","article-title":"UK Renal Registry 11th Annual Report (December 2008): Chapter 12: epidemiology of methicillin resistant Staphylococcus aureus bacteraemia amongst patients receiving renal replacement therapy in England in 2007","volume":"115","author":"Fluck","year":"2010","journal-title":"Nephron Clin Pract"},{"key":"10.1093\/bja\/aer461_bib46","doi-asserted-by":"crossref","first-page":"167","DOI":"10.2215\/CJN.06270710","article-title":"Nasal carriage of methicillin-resistant Staphylococcus aureus is associated with higher all-cause mortality in hemodialysis patients","volume":"6","author":"Chu","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"issue":"Suppl. 1","key":"10.1093\/bja\/aer461_bib47","doi-asserted-by":"crossref","first-page":"c261","DOI":"10.1159\/000301235","volume":"115","author":"Fluck","year":"2010","journal-title":"Nephron Clin Pract"},{"key":"10.1093\/bja\/aer461_bib48","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1038\/sj.ki.5001916","article-title":"Microbiology and outcomes of peritonitis in North America","volume":"103","author":"Mujais","year":"2006","journal-title":"Kidney Int Suppl"},{"key":"10.1093\/bja\/aer461_bib49","doi-asserted-by":"crossref","first-page":"393","DOI":"10.3747\/pdi.2010.00049","article-title":"Peritoneal dialysis-related infections recommendations: 2010 update","volume":"30","author":"Li","year":"2010","journal-title":"Perit Dial Int"},{"key":"10.1093\/bja\/aer461_bib50","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD005284.pub2","article-title":"Treatment for peritoneal dialysis-associated peritonitis","author":"Wiggins","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1093\/bja\/aer461_bib51","article-title":"High Rates of Mortality and Technique Failure in Peritoneal Dialysis Patients after Critical Illness","author":"Khan","year":"2011","journal-title":"Perit Dial Int"},{"key":"10.1093\/bja\/aer461_bib52","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1177\/089686080902900314","article-title":"Peritonitis remains the major clinical complication of peritoneal dialysis: the London, UK, peritonitis audit 2002\u20132003","volume":"29","author":"Davenport","year":"2009","journal-title":"Perit Dial Int"},{"key":"10.1093\/bja\/aer461_bib53","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3747\/pdi.2008.00258","article-title":"Staphylococcus aureus peritonitis in Australian peritoneal dialysis patients: predictors, treatment, and outcomes in 503 cases","volume":"30","author":"Govindarajulu","year":"2011","journal-title":"Perit Dial Int"},{"key":"10.1093\/bja\/aer461_bib54","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0140-6736(98)85044-7","article-title":"Potassium","volume":"352","author":"Halperin","year":"1998","journal-title":"Lancet"},{"key":"10.1093\/bja\/aer461_bib55","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1042\/cs0730247","article-title":"Evidence for large intestinal control of potassium homoeostasis in uraemic patients undergoing long-term dialysis","volume":"73","author":"Sandle","year":"1987","journal-title":"Clin Sci (Lond)"},{"key":"10.1093\/bja\/aer461_bib56","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/nrneph.2010.175","article-title":"Pathophysiology and management of hypokalemia: a clinical perspective","volume":"7","author":"Unwin","year":"2011","journal-title":"Nat Rev Nephrol"},{"key":"10.1093\/bja\/aer461_bib57","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/S0272-6386(12)80983-8","article-title":"Hypokalemic effects of intravenous infusion or nebulization of salbutamol in patients with chronic renal failure: comparative study","volume":"23","author":"Liou","year":"1994","journal-title":"Am J Kidney Dis"},{"key":"10.1093\/bja\/aer461_bib58","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003235.pub2","article-title":"Emergency interventions for hyperkalaemia","author":"Mahoney","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1093\/bja\/aer461_bib59","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1038\/ki.1990.284","article-title":"Albuterol and insulin for treatment of hyperkalemia in hemodialysis patients","volume":"38","author":"Allon","year":"1990","journal-title":"Kidney Int"},{"key":"10.1093\/bja\/aer461_bib60","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1177\/0310057X9001800114","article-title":"Suxamethonium and hyperkalaemia","volume":"18","author":"Yentis","year":"1990","journal-title":"Anaesth Intensive Care"},{"key":"10.1093\/bja\/aer461_bib61","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1097\/00000542-200601000-00022","article-title":"Succinylcholine-induced hyperkalemia in acquired pathologic states: etiologic factors and molecular mechanisms","volume":"104","author":"Martyn","year":"2006","journal-title":"Anesthesiology"},{"key":"10.1093\/bja\/aer461_bib62","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1172\/JCI108099","article-title":"The effect of potassium loading on sodium excretion and plasma renin activity in Addisonian man","volume":"56","author":"Miller","year":"1975","journal-title":"J Clin Invest"},{"key":"10.1093\/bja\/aer461_bib63","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s11255-004-6194-y","article-title":"Potassium metabolism in patients with chronic kidney disease. Part II: patients on dialysis (stage 5)","volume":"36","author":"Musso","year":"2004","journal-title":"Int Urol Nephrol"},{"key":"10.1093\/bja\/aer461_bib64","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1056\/NEJMcp0906797","article-title":"Clinical practice. Stage IV chronic kidney disease","volume":"362","author":"Abboud","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1093\/bja\/aer461_bib65","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1136\/bmj.39582.589433.BE","article-title":"Diagnosis and management of hypocalcaemia","volume":"336","author":"Cooper","year":"2008","journal-title":"Br Med J"},{"key":"10.1093\/bja\/aer461_bib66","first-page":"47","article-title":"Magnesium metabolism and its disorders","volume":"24","author":"Swaminathan","year":"2003","journal-title":"Clin Biochem Rev"},{"key":"10.1093\/bja\/aer461_bib67","first-page":"72","article-title":"Calcium flux in continuous venovenous haemodiafiltration with heparin and citrate anticoagulation","volume":"13","author":"Brain","year":"2010","journal-title":"Crit Care Resusc"},{"key":"10.1093\/bja\/aer461_bib68","first-page":"197","article-title":"Combination of calcitonin and pamidronate for emergency treatment of malignant hypercalcemia","volume":"5","author":"Sekine","year":"1998","journal-title":"Oncol Rep"},{"key":"10.1093\/bja\/aer461_bib69","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.4065\/83.9.1032","article-title":"Bisphosphonates: mechanism of action and role in clinical practice","volume":"83","author":"Drake","year":"2008","journal-title":"Mayo Clin Proc"},{"key":"10.1093\/bja\/aer461_bib70","doi-asserted-by":"crossref","first-page":"233","DOI":"10.5414\/CN106965","article-title":"Cinacalcet reduces plasma intact parathyroid hormone, serum phosphate and calcium levels in patients with secondary hyperparathyroidism irrespective of its severity","volume":"76","author":"Frazao","year":"2011","journal-title":"Clin Nephrol"},{"key":"10.1093\/bja\/aer461_bib71","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1007\/s001340050562","article-title":"Continuous venovenous hemodiafiltration (CVVHDF) with citrate anticoagulation in the treatment of a patient with acute renal failure, hypercalcemia, and thrombocytopenia","volume":"24","author":"Sramek","year":"1998","journal-title":"Intensive Care Med"},{"key":"10.1093\/bja\/aer461_bib72","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1515\/CCLM.1999.073","article-title":"A study of hypermagnesaemia in a hospital population","volume":"37","author":"Crook","year":"1999","journal-title":"Clin Chem Lab Med"},{"key":"10.1093\/bja\/aer461_bib73","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1093\/bja\/88.5.653","article-title":"Propofol metabolites in man following propofol induction and maintenance","volume":"88","author":"Favetta","year":"2002","journal-title":"Br J Anaesth"},{"key":"10.1093\/bja\/aer461_bib74","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/j.1365-2125.2005.02393.x","article-title":"Kidneys contribute to the extrahepatic clearance of propofol in humans, but not lungs and brain","volume":"60","author":"Hiraoka","year":"2005","journal-title":"Br J Clin Pharmacol"},{"key":"10.1093\/bja\/aer461_bib75","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/00000542-200502000-00014","article-title":"Human kidneys play an important role in the elimination of propofol","volume":"102","author":"Takizawa","year":"2005","journal-title":"Anesthesiology"},{"key":"10.1093\/bja\/aer461_bib76","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1007\/BF01705413","article-title":"The use of propofol for sedation of critically ill patients undergoing haemodiafiltration","volume":"21","author":"Eddleston","year":"1995","journal-title":"Intensive Care Med"},{"key":"10.1093\/bja\/aer461_bib77","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1592\/phco.27.3.389","article-title":"Clinical pharmacokinetic monitoring of midazolam in critically ill patients","volume":"27","author":"Spina","year":"2007","journal-title":"Pharmacotherapy"},{"key":"10.1093\/bja\/aer461_bib78","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/clpt.1992.84","article-title":"Pharmacokinetic-pharmacodynamic modeling of the central nervous system effects of midazolam and its main metabolite alpha-hydroxymidazolam in healthy volunteers","volume":"51","author":"Mandema","year":"1992","journal-title":"Clin Pharmacol Ther"},{"key":"10.1093\/bja\/aer461_bib79","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/BF03189348","article-title":"Pharmacokinetics of midazolam and its main metabolite 1-hydroxymidazolam in intensive care patients","volume":"23","author":"Boulieu","year":"1998","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"10.1093\/bja\/aer461_bib80","first-page":"149","article-title":"The effects of acute changes in renal function on the pharmacokinetics of midazolam during long-term infusion in ICU patients","volume":"42","author":"Driessen","year":"1991","journal-title":"Acta Anaesthesiol Belg"},{"key":"10.1093\/bja\/aer461_bib81","first-page":"311","article-title":"The influence of renal failure on the kinetics of intravenous midazolam: an \"in vitro\" and \"in vivo\" study","volume":"78","author":"Calvo","year":"1992","journal-title":"Res Commun Chem Pathol Pharmacol"},{"key":"10.1093\/bja\/aer461_bib82","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1053\/j.ajkd.2004.09.004","article-title":"Population pharmacokinetics of lorazepam and midazolam and their metabolites in intensive care patients on continuous venovenous hemofiltration","volume":"45","author":"Swart","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"10.1093\/bja\/aer461_bib83","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.ejpain.2007.07.009","article-title":"Morphine-6-glucuronide (M6G) for postoperative pain relief","volume":"12","author":"Dahan","year":"2008","journal-title":"Eur J Pain"},{"key":"10.1093\/bja\/aer461_bib84","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1046\/j.1440-1681.2000.03290.x","article-title":"Neuroexcitatory effects of morphine and hydromorphone: evidence implicating the 3-glucuronide metabolites","volume":"27","author":"Smith","year":"2000","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1093\/bja\/aer461_bib85","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/clpt.1993.127","article-title":"The pharmacokinetics of morphine and morphine glucuronides in kidney failure","volume":"54","author":"Osborne","year":"1993","journal-title":"Clin Pharmacol Ther"},{"key":"10.1093\/bja\/aer461_bib86","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/clpt.1988.12","article-title":"Pharmacokinetics and pharmacodynamics of codeine in end-stage renal disease","volume":"43","author":"Guay","year":"1988","journal-title":"Clin Pharmacol Ther"},{"key":"10.1093\/bja\/aer461_bib87","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1093\/ndt\/13.6.1535","article-title":"Removal of morphine with the new high-efficiency and high-flux membranes during haemofiltration and haemodiafiltration","volume":"13","author":"Jamal","year":"1998","journal-title":"Nephrol Dial Transplant"},{"key":"10.1093\/bja\/aer461_bib88","doi-asserted-by":"crossref","first-page":"2802","DOI":"10.1093\/ndt\/12.12.2802","article-title":"Removal of morphine but not fentanyl during haemodialysis","volume":"12","author":"Bastani","year":"1997","journal-title":"Nephrol Dial Transplant"},{"key":"10.1093\/bja\/aer461_bib89","first-page":"335","article-title":"Pain management in chronic kidney disease: the pharmacokinetics and pharmacodynamics of hydromorphone and hydromorphone-3-glucuronide in hemodialysis patients","volume":"4","author":"Davison","year":"2008","journal-title":"J Opioid Manag"},{"key":"10.1093\/bja\/aer461_bib90","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.jpainsymman.2004.02.021","article-title":"Opioids in renal failure and dialysis patients","volume":"28","author":"Dean","year":"2004","journal-title":"J Pain Symptom Manage"},{"key":"10.1093\/bja\/aer461_bib91","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1002\/j.1875-9114.1997.tb03750.x","article-title":"Fentanyl pharmacokinetics in patients undergoing renal transplantation","volume":"17","author":"Koehntop","year":"1997","journal-title":"Pharmacotherapy"},{"key":"10.1093\/bja\/aer461_bib92","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1213\/00000539-198701000-00009","article-title":"Pharmacokinetics of alfentanil in chronic renal failure","volume":"66","author":"Chauvin","year":"1987","journal-title":"Anesth Analg"},{"key":"10.1093\/bja\/aer461_bib93","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1097\/00000542-199709000-00012","article-title":"Pharmacokinetics and pharmacodynamics of remifentanil in persons with renal failure compared with healthy volunteers","volume":"87","author":"Hoke","year":"1997","journal-title":"Anesthesiology"},{"key":"10.1093\/bja\/aer461_bib94","doi-asserted-by":"crossref","first-page":"R21","DOI":"10.1186\/cc2399","article-title":"Offset of pharmacodynamic effects and safety of remifentanil in intensive care unit patients with various degrees of renal impairment","volume":"8","author":"Breen","year":"2004","journal-title":"Crit Care"},{"key":"10.1093\/bja\/aer461_bib95","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1681\/ASN.V133798","article-title":"New insights into diuretic use in patients with chronic renal disease","volume":"13","author":"Wilcox","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1093\/bja\/aer461_bib96","first-page":"S33","article-title":"Use of diuretics in chronic renal failure","volume":"59","author":"Suki","year":"1997","journal-title":"Kidney Int Suppl"},{"key":"10.1093\/bja\/aer461_bib97","doi-asserted-by":"crossref","first-page":"380","DOI":"10.2165\/00003495-199448030-00005","article-title":"Diuretic strategies in patients with renal failure","volume":"48","author":"Swan","year":"1994","journal-title":"Drugs"},{"key":"10.1093\/bja\/aer461_bib98","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1159\/000057416","article-title":"Diuretics in renal failure","volume":"25","author":"Andreucci","year":"1999","journal-title":"Miner Electrolyte Metab"},{"key":"10.1093\/bja\/aer461_bib99","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1053\/j.jrn.2004.09.024","article-title":"Inflammation and resistance to treatment with recombinant human erythropoietin","volume":"15","author":"Del Vecchio","year":"2005","journal-title":"J Ren Nutr"},{"key":"10.1093\/bja\/aer461_bib100","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1503\/cmaj.071055","article-title":"Erythropoietin-receptor agonists in critically ill patients: a meta-analysis of randomized controlled trials","volume":"177","author":"Zarychanski","year":"2007","journal-title":"Can Med Assoc J"},{"key":"10.1093\/bja\/aer461_bib101","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1093\/ndt\/gfg185","article-title":"Impaired expression of glycoproteins on resting and stimulated platelets in uraemic patients","volume":"18","author":"Moal","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"10.1093\/bja\/aer461_bib102","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1525-139X.2008.00556.x","article-title":"Treatment of bleeding in dialysis patients","volume":"22","author":"Galbusera","year":"2009","journal-title":"Semin Dial"},{"key":"10.1093\/bja\/aer461_bib103","doi-asserted-by":"crossref","first-page":"c107","DOI":"10.1159\/000158561","article-title":"Comparison of Tinzaparin and unfractionated heparin as anticoagulation on haemodialysis: equal safety, efficacy and economical parity","volume":"110","author":"Bramham","year":"2008","journal-title":"Nephron Clin Pract"},{"key":"10.1093\/bja\/aer461_bib104","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.1525-139X.2006.00177.x","article-title":"The safety of heparins in end-stage renal disease","volume":"19","author":"Sonawane","year":"2006","journal-title":"Semin Dial"},{"key":"10.1093\/bja\/aer461_bib105","doi-asserted-by":"crossref","first-page":"736","DOI":"10.2215\/CJN.03460807","article-title":"Safety and efficacy of regional citrate anticoagulation during 8-hour sustained low-efficiency dialysis","volume":"3","author":"Clark","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1093\/bja\/aer461_bib106","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1111\/j.1523-1755.2005.00342.x","article-title":"Regional citrate versus systemic heparin anticoagulation for continuous renal replacement in critically ill patients","volume":"67","author":"Kutsogiannis","year":"2005","journal-title":"Kidney Int"},{"key":"10.1093\/bja\/aer461_bib107","doi-asserted-by":"crossref","first-page":"c35","DOI":"10.1159\/000079925","article-title":"A simple, safe and effective citrate anticoagulation protocol for the genius dialysis system in acute renal failure","volume":"98","author":"Morgera","year":"2004","journal-title":"Nephron Clin Pract"},{"key":"10.1093\/bja\/aer461_bib108","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1592\/phco.29.5.562","article-title":"Antimicrobial dosing concepts and recommendations for critically ill adult patients receiving continuous renal replacement therapy or intermittent hemodialysis","volume":"29","author":"Heintz","year":"2009","journal-title":"Pharmacotherapy"},{"key":"10.1093\/bja\/aer461_bib109","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1097\/CCM.0b013e318206c3b2","article-title":"Antibiotic dosing during sustained low-efficiency dialysis: special considerations in adult critically ill patients","volume":"39","author":"Bogard","year":"2011","journal-title":"Crit Care Med"}],"container-title":["British Journal of Anaesthesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007091217324728?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007091217324728?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/bja\/article-pdf\/108\/2\/183\/1119761\/aer461.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T18:38:09Z","timestamp":1757788689000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0007091217324728"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":109,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["S0007091217324728"],"URL":"https:\/\/doi.org\/10.1093\/bja\/aer461","relation":{},"ISSN":["0007-0912"],"issn-type":[{"value":"0007-0912","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of the dialysis patient in general intensive care","name":"articletitle","label":"Article Title"},{"value":"British Journal of Anaesthesia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1093\/bja\/aer461","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 The Author(s). Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}